Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Korian (KORI) Ordinary Shares EUR5

Sell:€39.04 Buy:€39.08 Change: €0.36 (0.93%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€39.04
Buy:€39.08
Change: €0.36 (0.93%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€39.04
Buy:€39.08
Change: €0.36 (0.93%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Korian SA, formerly Korian Medica SA, is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly, offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Furthermore, the Company offers hospitalization at home, which avoids or shortens the hospitalization process; and home nursing services, which allows the care prescribes by a doctor at home. Korian-Medicas' establishments are located in France, Italy and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others.

Contact details

Address:
21-25 rue Balzac
PARIS
75008
France
Telephone:
+33 (1) 55375200
Website:
https://www.korian.fr/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
KORI
ISIN:
FR0010386334
Market cap:
€3.20 billion
Shares in issue:
81.94 million
Sector:
Health Care Facilities
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
Euronext Next 150

Key personnel

  • Christian Chautard
    Chairman of the Board
  • Sophie Boissard
    Chief Executive Officer
  • Philippe Garin
    Chief Financial Officer, Member of the Executive Committee
  • Frederic Durousseau
    Member of the Executive Committee - Director of Development and Real Estate
  • Remi Boyer
    Director of Human Resources and CSR, Member of the Executive Committee
  • Didier Armaingaud
    Member of the Executive Committee - Medical Director, Ethics and Group Quality
  • Dominiek Beelen
    Member of the Executive Committee - CEO Belgium
  • Bart Bots
    Member of the Executive Committee - Director of International Development
  • Caroline De Jessey
    Member of the Executive Committee - Group Director of Communication
  • Nicolas Merigot
    Member of the Executive Committee - CEO Health France

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.